Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration

Journal of Thoracic and Cardiovascular Surgery

Volumn 146, Issue 5, 2013, Pages

  Rosengart, Todd K ^a,b   Romeiser, Jamie L ^c   White, Lauren J ^c   Fratello, Ashley ^c   Fallon, Eleanor ^c   Senzel, Lisa ^c   Shroyer, Annie Laurie ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; CLOPIDOGREL; FRESH FROZEN PLASMA;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD; BLOOD TRANSFUSION REACTION; CARDIOVASCULAR RISK; CHEST TUBE; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PLATELET REACTIVITY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL MORTALITY; THROMBOCYTE; TREATMENT DURATION;

EID: 84885922152     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2013.06.029     Document Type: Article

References (27)

1. S.R. Steinhubl, P.B. Berger, J.T. Mann III, E.T. Fry, A. DeLago, and C. Wilmer Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420
2. E. Bennett-Guerrero, Y. Zhao, S.M. O'Brien, T.B. Ferguson Jr., E.D. Peterson, and J.S. Gammie Variation in use of blood transfusion in coronary artery bypass graft surgery JAMA 304 2010 1568 1575
3. D.M. Shahian, S.M. O'Brien, G. Filardo, V.A. Ferraris, C.K. Haan, and J.B. Rich The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1 - coronary artery bypass grafting surgery Ann Thorac Surg 88 2009 S2 S22
4. J.S. Berger, C.B. Frye, Q. Harshaw, F.H. Edwards, S.R. Steinhubl, and R.C. Becker Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis J Am Coll Cardiol 52 2008 1693 1701
5. R. Ebrahimi, C. Dyke, R. Mehran, S.V. Manoukian, F. Feit, and D.A. Cox Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial J Am Coll Cardiol 53 2009 1965 1972
6. P.A. Gurbel, E. Mahla, and U.S. Tantry Peri-operative platelet function testing: the potential for reducing ischaemic and bleeding risks Thromb Haemost 106 2011 248 252
7. A. Miceli, S.M. Duggan, G. Aresu, P.M. de Siena, F. Romeo, and M. Glauber Combined clopidogrel and aspirin treatment up to surgery increases the risk of postoperative myocardial infarction, blood loss and reoperation for bleeding in patients undergoing coronary artery bypass grafting Eur J Cardiothorac Surg 43 2012 722 728
8. S.V. Rao, K. O'Grady, K.S. Pieper, C.B. Granger, L.K. Newby, and F. Van de Werf Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Am J Cardiol 96 2005 1200 1206
9. S. Farzi, E. Mahla, H. Metzler, and A. Berghold The effect of preoperative treatment of P2Y12 receptor antagonists on perioperative bleeding and mortality in patients treated with coronary artery bypass grafting (CABG) Cochrane Database Syst Rev November 14, 2012 doi: 10.1002/14651858.CD010195
10. C.W. Hamm, J.P. Bassand, S. Agewall, J. Bax, E. Boersma, and H. Bueno ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2999 3054
11. D.J. Angiolillo, A. Fernandez-Ortiz, E. Bernardo, C. Ramirez, M. Sabate, and P. Jimenez-Quevedo Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease Diabetes 55 2006 780 784
12. C. Patrono, B. Coller, G.A. FitzGerald, J. Hirsh, and G. Roth Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 234S 264S
13. M. Pfisterer, H.P. Brunner-La Rocca, P.T. Buser, P. Rickenbacher, P. Hunziker, and C. Mueller Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2006 2584 2591
14. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, V.A. Ferraris, S.P. Ferraris, S.P. Saha, E.A. Hessel II, and C.K. Haan Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline Ann Thorac Surg 83 2007 S27 S86
15. H. Jneid, J.L. Anderson, R.S. Wright, C.D. Adams, C.R. Bridges, and D.E. Casey Jr. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 60 2012 645 681
16. P.A. Gurbel, K.P. Bliden, K.M. Hayes, J.A. Yoho, W.R. Herzog, and U.S. Tantry The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting J Am Coll Cardiol 45 2005 1392 1396
17. P. Jaremo, T.L. Lindahl, S.G. Fransson, and A. Richter Individual variations of platelet inhibition after loading doses of clopidogrel J Intern Med 252 2002 233 238
18. J.E. Mobley, S.J. Bresee, D.C. Wortham, R.M. Craft, C.C. Snider, and R.C. Carroll Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization Am J Cardiol 93 2004 456 458
19. A. Malinin, A. Pokov, L. Swaim, M. Kotob, and V. Serebruany Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel Methods Find Exp Clin Pharmacol 28 2006 315 322
20. M.J. Price, J.L. Coleman, S.R. Steinhubl, G.B. Wong, C.P. Cannon, and P.S. Teirstein Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers Am J Cardiol 98 2006 681 684
21. J. Tobin Estimation of relationships for limited dependent variables Econometrica 26 1958 24 36
22. L. Chen, A.W. Bracey, R. Radovancevic, J.R. Cooper Jr., C.D. Collard, and W.K. Vaughn Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting J Thorac Cardiovasc Surg 128 2004 425 431
23. C.R. Herman, K.J. Buth, B.A. Kent, and G.M. Hirsch Clopidogrel increases blood transfusion and hemorrhagic complications in patients undergoing cardiac surgery Ann Thorac Surg 89 2010 397 402
24. D. Sibbing, W. Koch, D. Gebhard, T. Schuster, S. Braun, and J. Stegherr Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement Circulation 121 2010 512 518
25. P.A. Gurbel, K.P. Bliden, B.L. Hiatt, and C.M. O'Connor Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity Circulation 107 2003 2908 2913
26. Y.L. Kwak, J.C. Kim, Y.S. Choi, K.J. Yoo, Y. Song, and J.K. Shim Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery J Am Coll Cardiol 56 2010 1994 2002
27. G. Patti, V. Pasceri, V. Vizzi, E. Ricottini, and G. Di Sciascio Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study) Am J Cardiol 107 2011 995 1000